Jett, J R <br/><br/>
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 1994 
 - 2321-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.11.2321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Platelet Disorders--etiology<br/>Carcinoma, Small Cell--mortality<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Interferon-gamma--adverse effects<br/>Lung Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Patient Compliance<br/>Platelet Count<br/>Recombinant Proteins<br/>Remission Induction<br/>Survival Analysis